Explore/

Cannabis Stocks

Cannabis Stocks

40.21k followers23 symbols -1.90% Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

23 symbols

To view the complete list, get the Yahoo Finance app

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • Cronos Group: Which Firms Upgraded the Target Price?
    Market Realist48 minutes ago

    Cronos Group: Which Firms Upgraded the Target Price?

    Following Altria’s news, Cronos Group (CRON) received target price upgrades from notable investment management companies. On average, four companies (MJ) upgraded Cronos Group’s target price by nearly 70%.

  • 4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
    Zacks3 hours ago

    4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019

    These are the factors that could send marijuana stocks and ETF high in 2019.

  • Cronos Group: Optimism in the Cannabis Industry
    Market Realist2 hours ago

    Cronos Group: Optimism in the Cannabis Industry

    In the last three days, Cronos Group (CRON) generated optimism in the cannabis industry (HMMJ). The market was wary about Aphria (APHA). Cronos Group’s optimism was fueled by Altria’s stake in the company.

  • Here's Why Marijuana Stocks Deserve Coal in Their Stockings This Year
    Motley Fool2 hours ago

    Here's Why Marijuana Stocks Deserve Coal in Their Stockings This Year

    Pot stock investors would have had a great year, if not for this.

  • Canadian Cities Voted against Private Cannabis Retail Stores
    Market Realist3 hours ago

    Canadian Cities Voted against Private Cannabis Retail Stores

    On December 12, Mississauga and Markham voted against opening private cannabis retail stores for now. The Mississauga city council voted 10-2 against allowing private cannabis retail stores to operate in the city. The Markham city council voted 12-1 against opening private cannabis retail stores.

  • Why Green Thumb Industries’ Stock Jumped over 10% Today
    Market Realist18 hours ago

    Why Green Thumb Industries’ Stock Jumped over 10% Today

    Around 1:05 PM EST, the stock posted a daily high near 14.80 Canadian dollars, up 11.7% from the previous day’s closing price. Today’s sharp recovery comes as a relief for Green Thumb investors (MJ) since the stock had lost about 40.9% in the fourth quarter as of yesterday. Constellation Brands (STZ), Scotts Miracle-Gro (SMG), and Molson Coors Brewing (TAP) are down 12.5%, down 16.0%, and up 1.7% quarter-to-date, respectively.

  • 3 Pot Stocks to Watch on Farm Bill & News from Trump, May, Retail Earnings
    Zacks21 hours ago

    3 Pot Stocks to Watch on Farm Bill & News from Trump, May, Retail Earnings

    Ryan McQueeney discusses President Trump's latest comments on the trade war and the impending vote of confidence facing U.K. Prime Minister Theresa May. He also recaps earnings results from the retail sector. Later, he highlights three cannabis stocks to watch as the farm bill passes.

  • Barrons.com22 hours ago

    California’s Pension Fund Says No to Tobacco Stocks but Yes to Marijuana Stocks

    The nation’s largest pension has mostly divested itself of tobacco and related stocks, but “Calpers” recently bought Tilray stock.

  • Why New Age Beverages Stock Popped Again Today
    Motley Fool22 hours ago

    Why New Age Beverages Stock Popped Again Today

    Shares of the CBD-beverage maker rose as the Farm Bill moved closer to becoming law.

  • Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November
    Motley Fool23 hours ago

    Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November

    This marijuana stock's performance over the next few years will likely heavily hinge upon sales of the newly launched epilepsy drug Epidiolex.

  • Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
    Zacksyesterday

    Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation

    Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation

  • Implied Volatility Surging for Cronos Group (CRON) Stock Options
    Zacksyesterday

    Implied Volatility Surging for Cronos Group (CRON) Stock Options

    Investors need to pay close attention to Cronos Group (CRON) stock based on the movements in the options market lately.

  • Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
    Market Realistyesterday

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer, the widely followed host of Mad Money on CNBC, gave his opinion on the deal between Cronos Group (CRON) and Altria on December 11. Cramer called Altria’s acquisition of a 45% stake in Cronos Group last week a “smart move” for Altria. This trend brings some concern for the growth trajectory of companies such as Altria.

  • New Zealand Joins the Legal Medical Cannabis Chorus
    Market Realistyesterday

    New Zealand Joins the Legal Medical Cannabis Chorus

    On December 11, New Zealand’s government made way for medical cannabis legalization. New Zealand already allowed a few patients to access medical cannabis. The new law makes medical cannabis widely accessible to more patients.

  • Valuations: Cannabis Companies Got Battered
    Market Realistyesterday

    Valuations: Cannabis Companies Got Battered

    In the previous part, we discussed that nine major cannabis stocks’ (HMMJ) forward EV-to-EBITDA multiples declined nearly 26% on average to 14.9x month-over-month.

  • Mavyret Is a Leading Drug in AbbVie’s HCV Franchise
    Market Realistyesterday

    Mavyret Is a Leading Drug in AbbVie’s HCV Franchise

    AbbVie (ABBV) reported global HCV (hepatitis C) franchise sales worth $862 million in the third quarter, a YoY (year-over-year) rise of more than 100% on both an operational and a reported basis. The company reported HCV sales of $444 million in the US market, a YoY rise of more than 100%. AbbVie also reported HCV sales of $418 million in international markets in the third quarter, YoY rises of 94.5% on a reported basis and 95.6% on an operational basis.

  • Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
    Zacks2 days ago

    Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest

    Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.

  • Zacks2 days ago

    Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO

    Gilead Sciences (GILD) names Roche's Daniel O'Day as the company's new Chairman and CEO.

  • Why Aphria, Ascena Retail Group, and New Age Beverages Jumped Today
    Motley Fool2 days ago

    Why Aphria, Ascena Retail Group, and New Age Beverages Jumped Today

    Find out why these stocks soared higher.

  • Market Realist2 days ago

    Is the Latest Farm Bill a Huge Gain for the Cannabis Industry?

    The new farm bill, which is expected to be voted on later this week, contained a lot of important changes. Senate Majority Leader Mitch McConnell championed the legislation for making industrial hemp legal in the United States. Legal hemp is proposed in the latest farm bill, which is expected to go to vote in the House this Wednesday, after which it is to go to the Senate.

  • Cannabis Stocks Have Hit a Low
    Market Realist2 days ago

    Cannabis Stocks Have Hit a Low

    Earlier in this series, we saw that cannabis stocks’ (SEED) forward EV-to-sales multiples were trading at an all-time low, which was confirmed by the EV-to-EBITDA multiple in the following chart.

  • Simply Wall St.2 days ago

    Should You Worry About Hydrogenics Corporation’s (NASDAQ:HYGS) CEO Pay?

    Daryl C. Wilson has been the CEO of Hydrogenics Corporation (NASDAQ:HYGS) since 2006. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Zacks2 days ago

    Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800

    Bristol-Myers (BMY) enters into a collaboration agreement with Vedanta Biosciences to study Opdivo clubbed with the latter's VE800 for treating patients with advanced or metastatic cancers.

  • Venclexta: A Solid Growth Driver for AbbVie in Future Years
    Market Realist2 days ago

    Venclexta: A Solid Growth Driver for AbbVie in Future Years

    AbbVie (ABBV) reported global Venclexta sales worth $96 million in the third quarter, a YoY (year-over-year) rise of more than 100% on both an operational and a reported basis. As per the company’s third-quarter earnings conference call, this performance was mainly attributable to the FDA’s approval of the drug in a broader R/R (relapsed/refractory) CLL (chronic lymphocytic leukemia) indication. The company reported Venclexta sales worth $69 million in the US market, a YoY rise of more than 100%.

  • Are Cannabis Stocks Trading Cheap?
    Market Realist2 days ago

    Are Cannabis Stocks Trading Cheap?

    Earlier in this series, we discussed how the average forward EV-to-sales multiple of nine Canadian cannabis (MJ) stocks were trading at an all-time low of 4.6x. Let’s look at each of the nine cannabis stocks that are part of the average multiple below.